Author: Yasunori Watanabe; Joel D. Allen; Daniel Wrapp; Jason S. McLellan; Max Crispin
Title: Site-specific analysis of the SARS-CoV-2 glycan shield Document date: 2020_3_28
ID: 63j4qc7d_11
Snippet: A mixture of oligomannose-type glycans and complex-type glycans can be found at sites N61, N122, N165, N603, N657, N717 and N1074 (Figure 2) . Of the 22 sites on the S protein, 10 contain significant populations of oligomannose-type glycans, highlighting how the processing of the SARS-CoV-2 S glycans is divergent from host glycoproteins. The remaining 12 sites are dominated by processed, complex-type glycans. The predominant category of complex-t.....
Document: A mixture of oligomannose-type glycans and complex-type glycans can be found at sites N61, N122, N165, N603, N657, N717 and N1074 (Figure 2) . Of the 22 sites on the S protein, 10 contain significant populations of oligomannose-type glycans, highlighting how the processing of the SARS-CoV-2 S glycans is divergent from host glycoproteins. The remaining 12 sites are dominated by processed, complex-type glycans. The predominant category of complex-type glycans observed on the S protein are fucosylated biantennary structures, very similar to those abundant on mammalian glycoproteins.
Search related documents:
Co phrase search for related documents- complex type and oligomannose type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- complex type and oligomannose type glycan: 1, 2, 3, 4
- complex type and significant population: 1
- complex type glycan and oligomannose type: 1, 2, 3, 4, 5
- complex type glycan and oligomannose type glycan: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date